care in Medical Technology

Overview of Pixantrone Phase III Clinical Data Presentation at American Society of Clinical Oncology 2009 Annual Meeting Now Available at Clinical Care Options

SEATTLE, June 10 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced today that a summary of the pixantrone Phase III clinical data that were presented at American Society of Clinical Oncology (ASCO) 2009 Annual Meeting on June 1, 2009 is now available at Cli...

CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement

CardioVascularCS.Org and CICT collaborate by reconstructing cardiovascular clinical experiences presented virtually at the annual CICT conference BOSTON, June 2 /PRNewswire/ -- The EndoVascular Forum, Inc. (EVF), an IC Sciences Company, and its partner Complex Interventional Cardiovascular T...

Final Results of Boceprevir Phase II HCV SPRINT-1 Study Showed Significantly Higher SVR Rates Compared to Standard of Care in Treatment-Naive Genotype 1 Hepatitis C Patients

48-week investigational regimen yielded nearly double SVR rate compared to standard of care Update on next-generation HCV protease inhibitor SCH 900518 presented at EASL annual meeting COPENHAGEN, Denmark, April 23 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) toda...

Hospital Care Varies Greatly for Children with Urinary Tract Infections

-Standardizing Care May Improve Quality, Reduce Hospital Stays- PHILADELPHIA, April 21 /PRNewswire-USNewswire/ -- More than 45,000 infants and children in the United States are hospitalized each year for urinary tract infections, but a new study reveals significant variability across hospital...

Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase

Harvard Pilgrim achieves CORE Phase II Testing Certification with Edifecs CORE Testing Service - includes compliance with rules that are now required in X12 Version 5010 BELLEVUE, Wash., April 5 /PRNewswire/ -- Edifecs announced today that it will, together with its partners CAQH and Harvar...

Unemployment, Health Care Spending Affect Mortality

FORT WORTH, Texas, March 13 /PRNewswire-USNewswire/ -- At the Health Industries Council meeting on March 11, in Irving, Harvey Brenner, Ph.D. and professor of public health and behavioral sciences at the University of North Texas Health Science Center's School of Public Health, announced new fin...

BioSpecifics Technologies Corp. to Present at Cowen and Company 29th Annual Health Care Conference

LYNBROOK, N.Y., March 10 /PRNewswire-FirstCall/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming Cowen ...

Spectral presents data on the clinical utility of EAA(TM) at 13th Annual Critical Care for Endotoxemia conference in Japan

TORONTO, Feb. 23 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI) today announced that it presented new findings demonstrating the clinical utility of its EAA(TM) Endotoxin Activity Assay, the only FDA cleared diagnostic for the measurement of endotoxin, at the 13th Annual Critical Car...

FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation

WOODCLIFF LAKE, N.J., Dec. 14 /PRNewswire/ -- Eisai Corporation of North America today announced that the U.S. Food and Drug Administration (FDA) has approved LUSEDRA(TM) (fospropofol disodium) Injection, an intravenous sedative-hypnotic agent for monitored anesthesia care (MAC) sedation in adult ...

Studies Examine Quality of Care for Hospitalized Sickle Cell Disease Patients and Effective Methods for Detecting Risk of Stroke in Children With This Disorder

SAN FRANCISCO, Dec. 6 /PRNewswire-USNewswire/ -- A study assessing the quality of care for patients with sickle cell disease in a variety of hospital settings will be presented at a press conference on Saturday, December 6, at 9:30 a.m., during the 50th Annual Meeting of the American Society of He...

Siemens Introduces New Standard of Care for Breast Ultrasound

Increased information density, automation and intelligent clinical applications take workflow efficiency in ultrasound to an all new level CHICAGO, Ill., Nov. 26 /PRNewswire-FirstCall/ -- Siemens Healthcare ( www.siemens.com/healthcare ) highlights the ACUSON S2000(TM) Automated Brea...

Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center

LOUISVILLE, Ky., Nov. 25 /PRNewswire-USNewswire/ -- Kleinert Kutz and University of Louisville hand surgeons performed the fifth U.S. hand transplant on Messina, New York resident, Jan "Erik" Hondusky, at Louisville's Jewish Hospital Hand Care Center on Monday, November 24. The innovative proce...

In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices

ALEXANDRIA, Va., Oct. 8 /PRNewswire-USNewswire/ -- The facts are overwhelming. Every day, nearly 7,000 people die from HIV/AIDS in sub-Saharan Africa. More than 35,000,000 women, children, and men in sub-Saharan Africa have already died of AIDS. The Foundation for Hospices in Sub-Saharan Afric...

Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures

PHILADELPHIA, Sept. 30 /PRNewswire-USNewswire/ -- The following is being released by The Philadelphia AIDS Consortium: WHO: Parent Organization: The Philadelphia AIDS Consortium in partnership with its network of eleven (11) community-based organization sites located throughout the tri-state...

Nation's Foremost Health Care Leaders Kick Off Summit Focused on Zero-Tolerance Approach to Hospital-Acquired Infections

Summit attendees say HAIs are most difficult preventable medical conditions to address; Hospitals must improve infection prevention awareness, education and training to reduce HAIs WASHINGTON, Sept. 9 /PRNewswire-FirstCall/ -- As health care providers brace for an October deadl...

Study Shows Use of AdvanDx's PNA FISH(TM) Test was Associated with an 82% Reduction in Intensive Care Unit Mortality Rates from Staphylococcus aureus Bloodstream Infections

WOBURN, Mass., July 15 /PRNewswire/ -- AdvanDx today announced that a new study shows use of AdvanDx's PNA FISH(TM) test was associated with an 82% reduction in mortality rates from S. aureus bloodstream infections in the intensive care unit (ICU), a 53% reduction in overall mortality from sta...

Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

Submission of Five-Day Dosing Regimen sNDA Targeted for Fiscal Year-end 2008 WOODCLIFF LAKE, N.J., July 1, 2008 /PRNewswire/ -- Eisai Corporation of North America today announced the preliminary efficacy data from a trial initiated in 2002 comparing Dacogen(R) ...

SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes

Reiterates 2008 Annual Financial Guidance DUBLIN, Calif., July 1 /PRNewswire-FirstCall/ -- SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, tod...

DaVita Strives to Improve Quality of Life and Reduce Overall Costs of Kidney Care Through Community-Based Education

EL SEGUNDO, Calif., June 23 /PRNewswire/ -- DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney failure and disease (CKD), recently introduced its EMPOWER program, a series of free community-based workshops that encourage CKD patients to take control...

Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System

SWARTZ CREEK, Mich., May 5 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that their proprietary and exclusive Electronic Navigator (eNAV(TM)) patient care system is now live and being utilized to manage their multiple sclerosis patients. The company plans to use eNAV(TM) as a dis...

Biomarkers May Reduce the Need for Biopsies and Offer Personalized Care for Heart and Lung Transplant Patients

BOSTON, April 10 /PRNewswire/ -- Data presented at this week's 28th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT) suggest the potential of a significant impact of using biomarkers to reduce the need for biopsies and personalize t...

QMed, Inc. Receives 2-Year Extension of Medicare Coordinated Care Demonstration Project by CMS

EATONTOWN, N.J., April 7, 2008 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED ) today announced it has been granted a two year operating extension from the Centers for Medicare and Medicaid Services (CMS) for its Medicare Coordinated Care Demonstration (MCCD) project in Northern Californ...

Influenza Vaccination Rates Among Health Care Personnel Remain Well Below National Goal

National Foundation for Infectious Diseases Highlights Critical Need for Improved Rates; Illustrates Best Practices BETHESDA, Md., Feb. 27 /PRNewswire/ -- In response to recent data revealing that only 42 percent of health care personnel have received their annual influenza vacci...

Aung FootHealth Clinics & Advanced Wound Care Center Enrolling Patients With Chronic Diabetic Foot Ulcers for Matrix Clinical Trial

TUCSON, Ariz., Feb. 4 /PRNewswire/ -- Aung FootHealth Clinics & Advanced Wound Care Center today announced it is recruiting patients with lower extremity diabetic foot ulcers to participate in the MATRIX clinical trial. The MATRIX trial will study the effects of Excellarate(TM) (GAM501) (Ad5PD...

Data Demonstrate that Obagi Medical Products' Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures

Study of more than 2,500 patients shows marked improvement of skin texture, color and overall appearance SAN ANTONIO, Feb. 1 /PRNewswire-FirstCall/ -- Obagi Medical Products, Inc. (Nasdaq: OMPI ), a leader in topical aesthetic and therapeutic skin health systems, announced ...

Study Says Allergy Shots Help Children, Reduce Health Care Costs

BioMedEcon Study, First of its Kind in US, Finds Allergy Immunotherapy Beneficial Even When Treatment Not Completed MOSS BEACH, Calif., Jan. 23 /PRNewswire/ -- BioMedEcon, a leading provider of health economics and outcomes research, today announced findings of a landmark study w...

TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY

New AcuCare Programs Automate the Interface between Health Assessments for Patients and the Generation of Customized Care Treatment Plans AUBURN, Calif., Jan. 22 /PRNewswire/ -- TCS Healthcare Technologies, an industry leader in the development of medical management software applications th...

New AVEENO(R) Eczema Care Product Line Offers Breakthrough Formulas to Help Manage the Signs and Symptoms of Eczema

SKILLMAN, N.J., Jan. 11 /PRNewswire/ -- According to the American Academy of Dermatology (AAD), 10-20 percent of the world's population suffers from eczema, an inflamed skin condition characterized by red, scaly and itchy skin. To help manage the condition's symptoms, which tend to flare up in...

Highmark Presents Work on MRSA Prevention at National Health Care Quality Conference

QualityBLUE program works with hospitals to help reduce spread of MRSA PITTSBURGH, Dec. 11 /PRNewswire/ -- At a national forum on quality in health care, Highmark officials presented information on one aspect of their pay-for-performance program designed to deal with Methicillin Resistant Sta...

Surface Logix, Inc. to Present at the Piper Jaffray Health Care Conference

BOSTON, Nov. 26 /PRNewswire/ -- Surface Logix, Inc. today announced that Jim Mahoney, President and Chief Executive Officer, will present an update of the company's drug development pipeline at the 19th Annual Piper Jaffray Health Care Conference being held November 27-29, 2007 at The Pierre H...

New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma

- Three large, randomized Phase III trials of VELCADE in front-line multiple myeloma to be featured as oral presentations at the American Society of Hematology (ASH) Annual Meeting - CAMBRIDGE, Mass., Nov. 26 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq:...

Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio

Seek-Find-Act-Follow: Innovations Span Entire Breast Care Continuum, from Early Detection and Diagnosis, to Targeted Therapy, Monitoring and After Care CHICAGO, Nov. 25 /PRNewswire-FirstCall/ -- Siemens Medical Solutions (http://www.usa.siemens.com/medical ) ...

New UNAIDS Report Offers Encouraging News, But Most HIV-Positive Mothers Still Not Getting the Care & Treatment They Need

WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following statement was released today by Pamela W. Barnes, President and Chief Executive Officer of the Elizabeth Glaser Pediatric AIDS Foundation: "Four years after the President's Emergency Plan for AIDS Relief (PEPFAR) began funding trea...

State, Federal Officials Remind Health Care Workers, Other at-Risk Individuals to Get Annual Flu Shot

HARRISBURG, Pa., Nov. 15 /PRNewswire-USNewswire/ -- Fewer than half of health care workers get an annual flu shot, prompting a reminder today from the Pennsylvania Department of Health and the federal Centers for Disease Control of the need for at-risk individuals to be vaccinated against infl...

Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer

Interim analysis of Phase 2 clinical data presented at the 2007 Chemotherapy Foundation Symposium BOULDER, Colo., Nov. 9 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM ) today released interim findings from its Phase 2 trial of Amrubicin in second-line chem...

An Open Letter to Parents, Students, School Administrators, & Health Care Officials from Soapopular(R)

NEW YORK, Nov. 8 /PRNewswire/ -- re: MRSA School Scare Every day brings new reports of students becoming infected -- and in some cases dying -- of MRSA (methicillin-resistant staphylococcus aureus), a potentially lethal form of staph infection that's easily acquired in public schools, univ...

Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease

MADISON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- The majority of people with diabetes and/or high blood pressure -- the two leading causes of chronic kidney disease (CKD) -- are not receiving recommended tests to identify this disease early, when medical treatment can slow or halt disease progr...

Lilly Receives NCQA Design Certification for Depression Care Management Program

INDIANAPOLIS, Nov. 6 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY ) has received Program Design Certification from the National Committee for Quality Assurance (NCQA) for its Tools that Empower(TM) Depression Care Management Program. Tools that Empower(TM) Depression Care Manag...

Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting

ORLANDO, Fla., Nov. 5 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) and The Sinai Center for Thrombosis Research at Sinai Hospital of Baltimore today announced results of the recently completed CLEAR PLATELETS 2 (Clopidogrel Loading with Eptifibatide to Arrest the Reactiv...

Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance

First step for performing important diagnostics in physician offices MADISON, N.J., Nov. 1 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the nation's leading provider of diagnostic testing, information and services, today announced that its HemoCue and Focus Diagnos...